Archive for the ‘FDA’ Category

Is MAHA a misdirection strategy? – by Mary Talley Bowden MD

December 26 | Posted by mrossol | FDA, MAHA, Medicine, Pharma, Transparency[non]

When COVID patients started trickling into my office March 2020, I saw my role as primarily one of a bystander. Source: Is MAHA a misdirection strategy? – by Mary Talley Bowden MD

Verified by ExactMetrics